LENSAR posts investor presentation highlighting ALLY robotic laser cataract surgery platform

Reuters2026/08/17 17:55

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

LENSAR outlined growth strategy around its ALLY robotic cataract laser system, targeting workflow efficiency, higher procedure conversion, and recurring revenue expansion.
Q2 2026 revenue USD 16.5 million, up 18% from Q2 2025; recurring revenue USD 13.69 million, up 20%.
Gross margin 59% in Q2 2026 versus 50% a year earlier; net income USD 3.54 million versus a USD 1.76 million loss.
Cash and investments USD 13.6 million at June 30, 2026 versus USD 20.3 million at June 30, 2025.
U.S. procedure share rose to 23.4% in Q2 2026; global installed base reached 445 systems, up 9% year over year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LENSAR Inc. published the original content used to generate this news brief on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

LENSAR posts investor presentation highlighting ALLY robotic laser cataract surgery platform

You may also like

Crypto prices